These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10542264)

  • 21. Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation.
    Kitamura K; Aota Si; Sakamoto R; Yoshikawa SI; Okazaki K
    Blood; 2000 Jun; 95(11):3371-9. PubMed ID: 10828018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.
    Lee EO; Kang JL; Chong YH
    J Biol Chem; 2005 Mar; 280(9):7845-53. PubMed ID: 15632190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
    Pulaski L; Landström M; Heldin CH; Souchelnytskyi S
    J Biol Chem; 2001 Apr; 276(17):14344-9. PubMed ID: 11278814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling.
    Nakao A; Afrakhte M; Morén A; Nakayama T; Christian JL; Heuchel R; Itoh S; Kawabata M; Heldin NE; Heldin CH; ten Dijke P
    Nature; 1997 Oct; 389(6651):631-5. PubMed ID: 9335507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad7 and Smad6 differentially modulate transforming growth factor beta -induced inhibition of embryonic lung morphogenesis.
    Zhao J; Shi W; Chen H; Warburton D
    J Biol Chem; 2000 Aug; 275(31):23992-7. PubMed ID: 10801843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
    Bitzer M; von Gersdorff G; Liang D; Dominguez-Rosales A; Beg AA; Rojkind M; Böttinger EP
    Genes Dev; 2000 Jan; 14(2):187-97. PubMed ID: 10652273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H; Ueno H; Ooshima A; Takeshita A
    J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells.
    Dunfield LD; Dwyer EJ; Nachtigal MW
    Endocrinology; 2002 Apr; 143(4):1174-81. PubMed ID: 11897669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells.
    Ishisaki A; Yamato K; Nakao A; Nonaka K; Ohguchi M; ten Dijke P; Nishihara T
    J Biol Chem; 1998 Sep; 273(38):24293-6. PubMed ID: 9733712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor.
    Shi W; Sun C; He B; Xiong W; Shi X; Yao D; Cao X
    J Cell Biol; 2004 Jan; 164(2):291-300. PubMed ID: 14718519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
    Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
    Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells.
    Hall BS; Pereira MA
    Infect Immun; 2000 Apr; 68(4):2077-81. PubMed ID: 10722604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.
    Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
    J Clin Invest; 2004 Jan; 113(2):253-64. PubMed ID: 14722617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line.
    Jörnvall H; Blokzijl A; ten Dijke P; Ibáñez CF
    J Biol Chem; 2001 Feb; 276(7):5140-6. PubMed ID: 11084022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
    Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
    Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
    J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
    Yan X; Zhang J; Pan L; Wang P; Xue H; Zhang L; Gao X; Zhao X; Ning Y; Chen YG
    Mol Cell Biol; 2011 Sep; 31(18):3700-9. PubMed ID: 21791611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.